Traverse 2024 Testosterone. There has been longstanding concern that testosterone replacement therapy may increase cardiovascular risk, as well as the risk of thromboembolic disease. The traverse trial was done with topical testosterone.

1 university of washington school of medicine, seattle, wa 98195, usa. May 27, 2024 39 comments.